Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Irradiated Donor Lymphocyte Infusion Plus High-dose Interleukin-2 in Patients With Metastatic Malignant Melanoma and Renal Cell Carcinoma

NCT01925118 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01925118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Irradiated Donor Lymphocyte Infusion Plus High-dose Interleukin-2 in Patients With Metastatic Malignant Melanoma and Renal Cell Carcinoma
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2013
Completion date
May 31, 2015
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant melanoma and renal cell carcinoma